Neurostimulation Devices – Market Insights – Europe (Supplemental)

The European neurostimulation device market has been strongly impacted by the COVID-19 pandemic; however, following a period of recovery, it will grow modestly. This growth is fueled by favorable demographic trends, new competitors entering the market, ongoing post market clinical studies and the ongoing product innovation to improve treatment efficacy and to address new indications. However, limited reimbursement and the preference for alternative treatments in the neurostimulation device market segments will limit the growth of the overall market.

This Medtech 360 Report provides high-level market metrics for neurostimulation devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2031.

Table of contents